- Home
- SLQT vs KROS Comparison
SLQT vs KROS Comparison
Compare SLQT & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- KROS
- Stock Information
- Founded
- SLQT 1999
- KROS 2015
- Country
- SLQT United States
- KROS United States
- Employees
- SLQT N/A
- KROS N/A
- Industry
- SLQT Specialty Insurers
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- SLQT Finance
- KROS Health Care
- Exchange
- SLQT Nasdaq
- KROS Nasdaq
- Market Cap
- SLQT 386.9M
- KROS 558.9M
- IPO Year
- SLQT 2020
- KROS 2020
- Fundamental
- Price
- SLQT $2.44
- KROS $14.53
- Analyst Decision
- SLQT Hold
- KROS Buy
- Analyst Count
- SLQT 2
- KROS 13
- Target Price
- SLQT $3.38
- KROS $20.63
- AVG Volume (30 Days)
- SLQT 1.0M
- KROS 487.4K
- Earning Date
- SLQT 05-12-2025
- KROS 08-06-2025
- Dividend Yield
- SLQT N/A
- KROS N/A
- EPS Growth
- SLQT N/A
- KROS N/A
- EPS
- SLQT N/A
- KROS 0.11
- Revenue
- SLQT $1,488,701,000.00
- KROS $214,713,000.00
- Revenue This Year
- SLQT $17.72
- KROS $5,006.76
- Revenue Next Year
- SLQT $13.05
- KROS N/A
- P/E Ratio
- SLQT N/A
- KROS $132.53
- Revenue Growth
- SLQT 20.41
- KROS 91657.70
- 52 Week Low
- SLQT $1.62
- KROS $9.12
- 52 Week High
- SLQT $6.86
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- SLQT 53.19
- KROS 64.67
- Support Level
- SLQT $2.35
- KROS $13.26
- Resistance Level
- SLQT $2.69
- KROS $14.68
- Average True Range (ATR)
- SLQT 0.13
- KROS 0.41
- MACD
- SLQT 0.03
- KROS 0.12
- Stochastic Oscillator
- SLQT 52.83
- KROS 89.35
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.